-
My Account
In App
My Account
Not Rated
|
Fund Size
(0.06% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 19-Nov-25 | 9987.90 | -0.12% | - | 0.01% | 142/241 |
| 1 Month | 24-Oct-25 | 10067.10 | 0.67% | - | 0.58% | 111/240 |
| 3 Month | 26-Aug-25 | 10168.40 | 1.68% | - | 3.97% | 185/236 |
| 6 Month | 26-May-25 | 10503.70 | 5.04% | - | 5.69% | 118/226 |
| YTD | 01-Jan-25 | 9808.90 | -1.91% | - | 4.58% | 167/212 |
| Since Inception | 27-Dec-24 | 9905.00 | -0.95% | -1.04% | 12.61% | 206/218 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 296 | 8.81% | 1.06% | 9.27% (Apr 2025) | 0% (Nov 2024) | 43.94 k | 0.00 |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 257.4 | 7.66% | 0.13% | 8.83% (Apr 2025) | 0% (Nov 2024) | 1.52 L | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 210.1 | 6.26% | -0.03% | 6.29% (Aug 2025) | 0% (Nov 2024) | 27.36 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 168 | 5.00% | -0.45% | 8.33% (Apr 2025) | 0% (Nov 2024) | 1.12 L | -4.90 k |
| Neuland Laboratories Ltd. | Pharmaceuticals | 137.4 | 4.09% | 0.31% | 4.09% (Oct 2025) | 0% (Nov 2024) | 8.34 k | 0.00 |
| Biocon Ltd. | Pharmaceuticals | 126.4 | 3.76% | 0.17% | 4.24% (Jan 2025) | 0% (Nov 2024) | 3.40 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 123 | 3.66% | -0.17% | 3.83% (Sep 2025) | 0% (Nov 2024) | 1.20 L | -7.23 k |
| Aurobindo Pharma Ltd. : Futures Near | Pharmaceuticals | 116.8 | 3.48% | 0.04% | 3.48% (Oct 2025) | 0% (Nov 2024) | 1.02 L | 0.00 |
| Piramal Pharma Ltd. | Pharmaceuticals | 108.9 | 3.24% | 0.01% | 3.98% (Jan 2025) | 0% (Nov 2024) | 5.45 L | 0.00 |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 108.2 | 3.22% | -0.04% | 3.45% (Aug 2025) | 0% (Nov 2024) | 82.00 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 4.38% |
| MF Units | MF Units | 1.49% |
| Net Receivables | Net Receivables | -1.68% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | 4.74 | 14.31 | 49.08 | 47.47 | 35.30 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | 0.07 | 3.95 | 16.36 | 29.06 | 14.93 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 1.91 | 9.74 | 17.91 | 23.12 | 0.00 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | 0.61 | 5.73 | 19.37 | 21.29 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | -1.33 | 6.96 | 16.62 | 20.60 | 12.34 |
| Nippon India Japan Equity Fund - Growth | NA | 292.35 | 0.82 | 3.35 | 10.88 | 20.26 | 15.03 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.80 | 9.54 | 7.36 | 19.10 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.63 | 10.90 | 9.19 | 18.78 | 13.63 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 3.19 | 9.44 | 11.05 | 18.43 | 19.80 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 3.44 | 9.92 | 9.31 | 17.54 | 17.39 |
Out of 23 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 1 is/are ranked 3 * , and 20 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Bajaj Finserv Money Market Fund - Regular Plan - Growth | 4 | 6101.32 | 0.51 | 1.37 | 2.98 | 7.05 | 0.00 |
| Bajaj Finserv Flexi Cap Fund - Regular Plan - Growth | NA | 6034.03 | 1.26 | 5.05 | 7.95 | 7.78 | 0.00 |
| Bajaj Finserv Liquid Fund - Regular Plan - Growth | 4 | 5996.06 | 0.48 | 1.42 | 2.90 | 6.50 | 0.00 |
| Bajaj Finserv Large and Mid Cap Fund - Regular Plan - Growth | NA | 2245.16 | 3.12 | 5.26 | 5.41 | 5.45 | 0.00 |
| Bajaj Finserv Large Cap Fund - Regular Plan - Growth | NA | 1666.14 | 2.01 | 6.77 | 5.85 | 5.92 | 0.00 |
| Bajaj Finserv Small Cap Fund - Regular Plan - Growth | NA | 1512.36 | 0.21 | 3.06 | 0.00 | 0.00 | 0.00 |
| Bajaj Finserv Balanced Advantage - Regular Plan - Growth | NA | 1325.24 | 2.03 | 6.02 | 5.16 | 7.37 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1283.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1283.50 | 2.33 | 9.92 | 11.13 | 13.91 | 0.00 |
| Bajaj Finserv Arbitrage Fund - Regular Plan - Growth | 3 | 1256.94 | 0.47 | 1.34 | 2.81 | 5.95 | 0.00 |
